GGrantIndex
← Search

ZIPRASIDONE IN TOURETTES SYNDROME, OBSESSIVE COMPULSIVE &PERVASIVE DEV. DISORDER

$0M01FY2000RRNIH

Yale University, New Haven CT

Investigators

Linked publications & trials

Abstract

The purpose of this study is evaluate the long-term effectiveness and safety of ziprasidone in the treatment of children and adults with Tourettes syndrome, Obsessive-Compulsive disorder, and Pervasive Development Disorder. Thirty (30) subjects (10 in each diagnosic group) will be enrolled in a one-year, open-label study.

View original record on NIH RePORTER →
ZIPRASIDONE IN TOURETTES SYNDROME, OBSESSIVE COMPULSIVE &PERVASIVE DEV. DISORDER · GrantIndex